Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Vilazodone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthetic method for 3-alkyl-substituted indoles via safe reduction. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel coumarin-based route for Vilazodone intermediate offers higher yield and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Novel NaBH4/TFA reduction route improves yield to 80% and purity, offering significant cost reduction in API manufacturing.
Novel zinc-catalyzed route for 3-(4-chlorobutyl)-5-cyanoindole. Avoids Lewis acids, ensures high purity and scalable production for global supply chains.
Patent CN111087340B reveals a novel one-step Friedel-Crafts alkylation for Vilazodone intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel zinc-mediated cyclization patent CN106928119A offers high yield Vilazodone intermediate with reduced waste and scalable production capabilities for global supply chains.
Patent CN103360374B reveals high-yield Vilazodone synthesis. Discover cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain solutions.
Patent CN103664911B reveals metal catalytic coupling for Vilazodone intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN102964287A reveals a greener Fischer indole route for Vilazodone intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Advanced manufacturing route for Vilazodone intermediates utilizing microwave cyanation and efficient piperazine cyclization, offering high purity and scalable production for pharmaceutical supply chains.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Novel patent CN102690224A details a cost-effective route for 3-(4-chlorobutyl)-1H-5-cyanoindole, replacing pyrophoric catalysts with stable reagents for scalable API production.
Patent CN102267985A reveals a scalable route for Vilazodone HCl, eliminating hazardous Lewis acids and precious metals for cost-effective pharmaceutical manufacturing.
Novel zinc-mediated route for Vilazodone intermediate. High yield, low waste, scalable production for pharma supply chains ensuring reliability and cost efficiency globally for all buyers.
Patent CN102964287B reveals a green Fischer indole route for 3-(4-chlorobutyl)-5-cyanoindole, offering safer API manufacturing and reduced supply chain risks.